Our results strongly support this hypothesis, with an observed reduction in recruited IBA1+ cells and microglial/macrophage markers, as well as a downregulation in several notable immune pathways known to be propagated by these immune cells and involved in AMD disease progression (Rutar et al., 2015; Jiao et al., 2018). This evidence concerns the gene AIF1 and age-related macular degeneration.